CD9 and glioblastoma: There has been a similar report from Engström et al. [14], who identified CD9 as one of the top five candidates to distinguish GSCs from NSCs in high-throughput sequencing of transcript tags (Tag-seq) performed on adherent GBM-derived NSCs and normal NSCs.